Lexicon Pharmaceuticals Inc. (LXRX) Awarded Fast Track Designation for Development of Carcinoid Syndrome Treatment
According to the American Cancer Society, about 11,000 to 12,000 neuroendocrine tumors and neuroendocrine cancers are diagnosed each year in…